On the heels of Tezspire ap­proval in US, Am­gen will add fill­ing line in Ire­land

On the heels of a big FDA ap­proval last week for its key­stone asth­ma drug, Am­gen is adding on at its Irish man­u­fac­tur­ing site.

Am­gen’s site in Dún Laoghaire is about to get a $100 mil­lion up­grade to im­prove its for­mu­la­tion, asep­tic drug prod­uct fill­ing, lyophili­sa­tion and pack­ag­ing op­er­a­tions as the com­pa­ny cel­e­brates its 10th year in Ire­land. The ad­di­tion will add an­oth­er 150 jobs for con­struc­tion work­ers in the Dublin sub­urb. The project is set to be the com­pa­ny’s largest out­side of North Amer­i­ca.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.